#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    ABO haemolytic disease of newborn Vulval cancer Scedosporium infection Cystic fibrosis Thrombocytopenia Castleman's disease Hereditary angioedema Follicular lymphoma stage I Hormone-dependent prostate cancer Neonatal alloimmune thrombocytopenia Facioscapulohumeral muscular dystrophy Plasma cell myeloma recurrent Acute myeloid leukaemia recurrent Iron overload Breast cancer metastatic More trials…

    Learn about Rare Diseases

    Mucopolysaccharidosis III – Life with Disease Mucopolysaccharidosis – Diagnostics Urea cycle disorder Alexander disease – Basic Information SAPHO syndrome – Life with Disease Hyperoxaluria – Treatment Gastrointestinal stromal tumour – Basic Information Medulloblastoma recurrent – Trials in Disease Alternating hemiplegia of childhood IgA nephropathy – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    68Ga-Nota-Abscint-Her2 Gadoteridol TALADEGIB IDP-121 PARECOXIB Abc-31-116 Acetic Acid, Glacial Toripalimab Pioglitazone Hydrochloride Vindesine Sulfate Gsk4011499 Eight Treg Osteodex SURVODUTIDE Simoctocog Alfa GLYCYL-TYROSINE Gs-5718-03 PRILOCAINE HYDROCHLORIDE Sar-443579 Agrostis Stolonifera Pollen More therapies…

    Learn about Your Condition

    Thyroid cancer Systemic infection Plasma cell myeloma recurrent Mechanical ventilation Hyperinsulinism Dry mouth HIV infection Circulatory collapse Pneumonia chlamydial Spinal muscular atrophy Chorioretinitis Multiple sclerosis Anal cancer Liposarcoma metastatic Lung transplant More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Digestive System Diseases

  • A study to evaluate the long-term safety and effectiveness of balinatunfib in adults with Crohn’s disease or ulcerative colitis

    Not recruiting

    2 1
    Austria Belgium Bulgaria Croatia Czechia France +8

  • A study of the effects of AGMB-129 and midazolam in healthy participants

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • ORG-129
    • Midazolam
    Belgium

  • A Study Comparing How the Body Absorbs Cefixime in Healthy Volunteers

    Not recruiting

    1 1 1 1
    Investigated Drugs:
    • Cefixime
    • Cefixime Trihydrate
    Romania

  • A study comparing how ritlecitinib capsules work when sprinkled on food versus swallowed whole and with or without food in healthy adults

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Vitiligo
    • Alopecia areata
    • Rheumatoid arthritis
    Belgium

  • A Study to Evaluate the Long-Term Safety of Glepaglutide in Adult Patients with Short Bowel Syndrome Who Participated in Previous Studies

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Short-bowel syndrome
    Investigated Drugs:
    • Glepaglutide
    Belgium France Germany Poland

  • Study comparing how the body processes GB1211 capsule and tablet forms with and without food in healthy volunteers

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Hepatic fibrosis
    • Non-small cell lung cancer
    Investigated Drugs:
    • 2-(5-BROMOPYRIDIN-3-YL)SULFANYL-6-(HYDROXYMETHYL)-4-[4-(3,4,5-TRIFLUOROPHENYL)TRIAZOL-1-YL]OXANE-3,5-DIOL
    • 5-Bromopyridin-3-Yl 3-Deoxy-1-Thio-3-[4-(3,4,5-Trifluorophenyl)-1H-1,2,3-Triazol-1-Yl]-Alfa-D-Galactopyranoside
    The Netherlands
Previous Page
1 … 58 59 60 61 62 … 93
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!